MPMarieke Pingen

Marieke Pingen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marieke Pingen has a total of 226 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Chemokine receptor expression defines a trajectory from monocytes to mature macrophages in the lung

    by Heather Mathie, Laura Medina-Ruiz, Fabian Schuette, Heba Halawa, Zuzanna Pocalun, Elise Pitmon, John Cole, Marieke Pingen, Gerard J Graham

    CCR1, CCR2, and CCR5 direct recruitment of monocytes and macrophages in inflammation. However, the discrete role for each receptor in monocyte/macrophage biology remains poorly understood, with previous reports citing receptor redundancy. Using transcriptomic approaches to examine inflammatory chemokine receptor expression on lung interstitial macrophage populations, we demonstrate that interstitial macrophages can be divided into 3 distinct subsets, each of which express specific patterns of chemokine receptors, and that there are dynamic changes in chemokine receptor expression as macrophages differentiate from monocytes in the lung. Furthermore, macrophages expressing different combinations of chemokine receptors are transcriptionally distinct, suggesting nonredundant functions for CCR1, CCR2, and CCR5. Finally, we examined changes in macrophage chemokine receptor expression in vitro after treatment with varied Toll-like receptor ligands and show that CCR1 is specifically increased in response to bacterial but not viral ligands. Our data provide compelling evidence that macrophage chemokine receptor expression is not redundant, but rather is specific and malleable in response to discrete inflammatory stimuli.


  • When viral RNA lingers in joints

    by Clive S. McKimmie, Marieke Pingen


  • Open Access

    Lung structural cells are altered by influenza virus leading to rapid immune protection following re-challenge

    by Julie C. Worrell, Kerrie E. Hargrave, George E. Finney, Chris Hansell, John Cole, Jagtar Singh Nijjar, Fraser Morton, Marieke Pingen, Tom Purnell, Kathleen Mitchelson, et al.

    Lung structural cells form barriers against pathogens and trigger immune responses following infections. This leads to the recruitment of innate and adaptive immune cells some of which remain within the lung and contribute to enhanced pathogen control following subsequent infections. There is growing evidence that structural cells also display long-term changes following infection. Here we investigate long-term changes to mouse lung epithelial cells, fibroblasts, and endothelial cells following influenza virus infection finding that all three cell types maintain an imprint of the infection, particularly in genes linked to communication with T cells. MHCI and MHCII proteins continue to be expressed at higher levels in both differentiated epithelial cells and progenitor populations and several differentially expressed genes are downstream of the transcription factor, SpiB, a known orchestrator of antigen presentation. Lung epithelial cells from influenza-infected mice display functional changes, more rapidly controlling influenza virus than cells from naïve animals. This rapid anti-viral response and increased expression of molecules required to communicate with T cells demonstrates sustained and enhanced functions following infection. These data suggest lung structural cells display characteristics of immune memory which could affect outcomes that are protective in the context of infection or pathogenic in chronic inflammatory disorders.


  • Open Access

    Inflammatory chemokine receptors CCR1, CCR2, CCR3 and CCR5 are essential for an optimal T cell response to influenza

    by Marieke Pingen, Catherine E. Hughes, Laura Medina-Ruiz, Heather Mathie, Jennifer A. Barrie, Chris Ah Hansell, Robin Bartolini, Megan KL MacLeod, Gerard J Graham


  • Open Access

    Inflammatory chemokine receptors CCR1, CCR2, CCR3 and CCR5 are essential for an optimal T cell response to influenza

    by Marieke Pingen, Catherine E. Hughes, Laura Medina-Ruiz, Heather Mathie, Jennifer A. Barrie, Chris Ah Hansell, Robin Bartolini, Megan KL MacLeod, Gerard J Graham

    Inflammatory chemokine receptors CCR1/2/3/5 (iCCRs) play an important role in the recruitment of immune cells involved in innate immune functions and orchestrating the adaptive immune response. Here we utilise an influenza A virus (IAV) challenge to investigate the combinatorial roles of the iCCRs in the anti-IAV immune response. We did not observe any gross differences in infection-driven pathology in the absence of iCCRs. Despite iCCR deletion resulting in decreased migration of monocytes, migratory macrophages and B cells to lungs during acute IAV infection, no differences in dendritic cell numbers were observed. Whilst the total number of T cells was similar in lungs of iCCR-deficient mice, the number of IAV-specific CD4 but not CD8 T cells in the lung was strongly reduced in the absence of iCCRs. Furthermore, fewer CD4, but not CD8, T cells produced IFN-γ. This CD4 T cell phenotype persisted into the memory stage of infection, with fewer IAV-specific and IFN-γ + CD4 but not CD8 T cells at 29 days post infection. In conclusion, despite having no impact on dendritic cell migration between the lung and the draining lymph node, iCCR deletion is associated with an altered CD4 T cell response to IAV infection.

  • Open Access

    Inflammation’s impact on the interaction between oligodendrocytes and axons

    by Tabitha R F Green, Marieke Pingen, Julia M Edgar

    Oligodendrocytes are responsible for the myelination of axons and providing trophic and metabolic support to the myelinated axon. They also interact with immune effector cells, including microglia and T cells, hence, are involved in central nervous system immune regulation. Given the crucial roles for oligodendrocytes and myelin in axonal function and maintenance, dysfunction, whether through cell death, myelin injury and loss, or failure in normal myelin formation, impairs neurological function. In diseases such as multiple sclerosis, the leukodystrophies, and viral infection, neuroinflammation is an important effector of myelin injury, having secondary consequences for the myelinated axon. In this review, we discuss the role of oligodendrocytes in health and inflammatory disease, with a focus on the interplay between inflammation and oligodendrocyte-axon interactions.


  • Open Access

    Enhanced CCR2 expression by ACKR2-deficient NK cells increases tumoricidal cell therapy efficacy

    by Alan J Hayes, Marieke Pingen, Gillian Wilson, Chris Hansell, Samantha Love, Paul Burgoyne, Daniel McElroy, Robin Bartolini, Francesca Vidler, Fabian Schuette, et al.

    Chemokines regulate leukocyte navigation to inflamed sites and specific tissue locales and may therefore be useful for ensuring accurate homing of cell therapeutic products. We, and others, have shown that atypical chemokine receptor 2 (ACKR2), deficient mice (ACKR2-/-) are protected from metastasis development in cell line and spontaneous mouse models. We have shown that this relates to enhanced CCR2 expression on ACKR2-/- NK cells allowing them to home more effectively to CCR2 ligand expressing metastatic deposits. Here we demonstrate that the metastatic-suppression phenotype in ACKR2-/- mice is not a direct effect of the absence of ACKR2. Instead, enhanced NK cell CCR2 expression is caused by passenger-mutations that originate from creation of the ACKR2-/- mouse strain in 129 embryonic stem cells. We further demonstrate that simple selection of CCR2+ NK cells enriches for a population of cells with enhanced anti-metastatic capabilities. Given the widespread expression of CCR2 ligands by tumors, our study highlights CCR2 as a potentially important contributor to NK cell tumoricidal cell therapy.


  • Open Access

    Lung structural cells are altered by influenza virus leading to rapid immune protection following re-challenge

    by Julie C. Worrell, Kerrie E. Hargrave, George E. Finney, Chris Hansell, John Cole, Jagtar Singh Nijjar, Fraser Morton, Marieke Pingen, Tom Purnell, Kathleen Mitchelson, et al.

    Lung structural cells, including epithelial cells and fibroblasts, form barriers against pathogens and trigger immune responses following infections such as influenza A virus. This response leads to the recruitment of innate and adaptive immune cells required for viral clearance. Some of these recruited cells remain within the lung following infection and contribute to enhanced viral control following subsequent infections. There is growing evidence that structural cells can also display long-term changes following infection or insults. Here we investigate long-term changes to mouse lung epithelial cells, fibroblasts, and endothelial cells following influenza virus infection and find that all three cell types maintain an imprint of the infection, particularly in genes associated with communication with T cells. Lung epithelial cells from IAV-infected mice display functional changes by more rapidly controlling influenza virus than cells from naïve animals. This rapid anti-viral response and increased expression of molecules required to communicate with T cells demonstrates sustained and enhanced functions following infection. These data suggest lung structural cells could be effective targets for vaccines to boost durable protective immunity. Graphical Highlights: Lung epithelial cells, fibroblasts, and blood endothelial cells maintain an inflammatory imprint of influenza A virus (IAV) infection for at least 40 days post-infection. In vivo re-infection leads to a more spatially restricted anti-viral response compared to primary IAV-infected animals. T cells are not required for enhanced viral control early after re-infection in vivo Ex vivo lung epithelial cells from IAV-infected mice more rapidly control IAV than cells from naïve animals in the absence of immune cells.


  • Establishing Mixed Neuronal and Glial Cell Cultures from Embryonic Mouse Brains to Study Infection and Innate Immunity

    by Alistair Gamble, Maria Suessmilch, Anniek Bonestroo, Andres Merits, Gerard J. Graham, Jonathan Cavanagh, Julia M. Edgar, Marieke Pingen

    Models of the central nervous system (CNS) must recapitulate the complex network of interconnected cells found in vivo. The CNS consists primarily of neurons, astrocytes, oligodendrocytes, and microglia. Due to increasing efforts to replace and reduce animal use, a variety of in vitro cell culture systems have been developed to explore innate cell properties, which allow the development of therapeutics for CNS infections and pathologies. Whilst certain research questions can be addressed by human-based cell culture systems, such as (induced) pluripotent stem cells, working with human cells has its own limitations with regard to availability, costs, and ethics. Here, we describe a unique protocol for isolating and culturing cells from embryonic mouse brains. The resulting mixed neural cell cultures mimic several cell populations and interactions found in the brain in vivo. Compared to current equivalent methods, this protocol more closely mimics the characteristics of the brain and also garners more cells, thus allowing for more experimental conditions to be investigated from one pregnant mouse. Further, the protocol is relatively easy and highly reproducible. These cultures have been optimized for use at various scales, including 96-well based high throughput screens, 24-well microscopy analysis, and 6-well cultures for flow cytometry and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis. This culture method is a powerful tool to investigate infection and immunity within the context of some of the complexity of the CNS with the convenience of in vitro methods.


  • Open Access

    Triphasic production of IFNγ by innate and adaptive lymphocytes following influenza A virus infection

    by George E Finney, Kerrie E Hargrave, Marieke Pingen, Thomas Purnell, David Todd, Freya MacDonald, Julie C Worrell, Megan KL MacLeod

    Interferon gamma (IFN γ ) is a potent antiviral cytokine that can be produced by many innate and adaptive immune cells during infection. Currently, our understanding of which cells produce IFN γ and where they are located at different stages of an infection are limited. We have used reporter mice to investigate in vivo expression of IFN γ in the lung and secondary lymphoid organs during and following influenza A virus (IAV) infection. We observed a triphasic production of IFN γ expression. Unconventional T cells and innate lymphoid cells, particularly NK cells, were the dominant producers of early IFN γ , while CD4 and CD8 T cells were the main producers by day 10 post-infection. Following viral clearance, some memory CD4 and CD8 T cells continued to produce IFN γ in the lungs and draining lymph node. Interestingly, IFN γ production by lymph node Natural Killer (NK), NKT and innate lymphoid 1 cells also continued to be above naïve levels, suggesting memory-like phenotypes for these cells. Analysis of the localisation of IFN γ + memory CD4 and CD8 T cells demonstrated that cytokine+ T cells were located near airways and in the lung parenchyma. Following a second IAV challenge, lung IAV specific CD8 T cells rapidly increased their expression of IFN γ while CD4 T cells in the draining lymph node increased their IFN γ response. Together, these data suggest that IFN γ production fluctuates based on cellular source and location, both of which could impact subsequent immune responses.